EU for Evibodies
By Kate McDonald
Monday, 09 February, 2009
Monday, 09 February, 2009
Arana Therapeutics has been granted an EU patent for its Evibodies range of small antibodies.
Evibodies were part of the technology platform brought into the company by EvoGenix when it merged with Peptech in 2007.
Evibodies are small fragments of a family of proteins that act like antibodies but are about one-tenth smaller.
They were given a US patent in 2007.
Related News
NSW Govt delivers foot-and-mouth vaccine to protect livestock
A biodegradable vaccine to protect livestock from foot-and-mouth disease has been developed as...
Scientists optimise delivery of mRNA to target cells
A highly versatile new method captures and attaches antibodies to the surface of mRNA-loaded...
'Anti-reward' brain network helps explain cocaine addiction
A new study identifies a specific 'anti-reward' network deep in the brain that undergoes...
